Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-CA-17-051

Pediatric Immunotherapy Translational Science Network (PI-TSN)(U01)

Closed on December 19, 2017.

Posted
September 26, 2017
Close date
December 19, 2017
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
5
5 new
Median first-year cost
$2,931,750
$12,985,966 in all
Institutions
5
5 contact PIs
Patents
1
from 1 funded project

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. CHILDREN'S HOSP OF PHILADELPHIA1
  2. FRED HUTCHINSON CANCER RESEARCH CENTER1
  3. INDIANA UNIVERSITY INDIANAPOLIS1
  4. RESEARCH INST NATIONWIDE CHILDREN'S HOSP1
  5. UNIVERSITY OF COLORADO DENVER1

Most frequent study sections

  1. Special Emphasis Panel (ZRG1 OTC-Y (56))5
5 awards under RFA-CA-17-051 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2018Multispecific targeting incorporating cytokine receptor pathways in high risk pediatric acute leukemias to improve durability of adoptive cell therapy-induced remissions1U01CA232486-01Fry, Terry J.Tasian, Sarah KathleenUNIVERSITY OF COLORADO DENVER, COFirst-year cost $3,950,741Study section ZRG1
FY2018Metabolic reprogramming of tumor microenvironment to maximize immunotherapy for pediatric cancers1U01CA232488-01Wang, RuoningRESEARCH INST NATIONWIDE CHILDREN'S HOSP, OHFirst-year cost $3,370,657Study section ZRG1
FY2018Cassette exons in neoplastic pro-B-cells: implications for immunotherapy1U01CA232563-01Barash, YosephThomas-Tikhonenko, AndreiCHILDREN'S HOSP OF PHILADELPHIA, PAFirst-year cost $2,931,750Study section ZRG1
FY2018Combinations of Synergistic Bispecific Human Antibodies: A Novel Strategy for the Treatment of Neuroblastoma1U01CA232490-01Olson, James MFRED HUTCHINSON CANCER RESEARCH CENTER, WAFirst-year cost $1,543,917Study section ZRG1
FY2018Dual targeting of tumoral microenvironment and tumoral cells by blocking the IL-33/ST2 pathway1U01CA232491-01Cheung, Nai-Kong VPaczesny, SophieINDIANA UNIVERSITY INDIANAPOLIS, INFirst-year cost $1,188,901Study section ZRG1
Newest fiscal year first, then first-year cost.

Patents from its funded projects

1 patent names 1 of the 5 funded projects.

  1. US 12,441,794 (opens the patent at USPTO, a PDF, in a new tab)ANTIBODIES FOR THE DIAGNOSIS AND TREATMENT OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIAGranted October 14, 2025 to THE CHILDREN'S HOSPITAL OF PHILADELPHIAU01CA232563 · CHILDREN'S HOSP OF PHILADELPHIA, PA

Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.

Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-21-0.3.10. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-CA-17-051: Pediatric Immunotherapy Translational Science Network (PI-TSN)(U01) | ConductScience ScienceDex